378 results on '"Fairchild, Paul"'
Search Results
2. Boosting Antitumour Immunity through Targeted Delivery of Interferon-α
3. Evasion of Pre-Existing Immunity to Cas9: a Prerequisite for Successful Genome Editing In Vivo?
4. Donor-Specific Transplantation Tolerance: The Paradoxical Behavior of CD4+ CD25+ T Cells
5. Harnessing the properties of dendritic cells in the pursuit of immunological tolerance
6. Regulation of CD40 Function by Its Isoforms Generated through Alternative Splicing
7. Thymic Involution: A Barrier or Opportunity for Cell Replacement Therapy?
8. Mitigating the Risk of Immunogenicity in the Pursuit of Induced Pluripotency
9. The role of dendritic cells in selection of the T cell repertoire
10. Differentiation of Dendritic Cells from Human Induced Pluripotent Stem Cells
11. Infiltrating the immunological synapse: prospects for the use of altered peptide ligands for the treatment of immune pathology
12. Regulatory T-cells in Therapeutic Transplantation Tolerance
13. Challenges and Opportunities in the Development of Induced Pluripotent Stem Cell Therapeutics
14. The adaptive immune response to cardiac injury—the true roadblock to effective regenerative therapies?
15. Infectious Tolerance via the Consumption of Essential Amino Acids and mTOR Signaling
16. Embryonic Stem Cell-Derived Tissues Are Immunogenic but Their Inherent Immune Privilege Promotes the Induction of Tolerance
17. Regulation and Privilege in Transplantation Tolerance
18. Embryonic stem cells: protecting pluripotency from alloreactivity
19. Cell replacement therapy and the evasion of destructive immunity
20. Towards the rational design of a next-generation dendritic cell vaccine for cancer immunotherapy
21. Differentiation of Dendritic Cells from Human Induced Pluripotent Stem Cells
22. Immune Privilege of Stem Cells
23. Mitigating the Risk of Immunogenicity in the Pursuit of Induced Pluripotency
24. Thymic Involution: A Barrier or Opportunity for Cell Replacement Therapy?
25. Donor-specific transplantation tolerance: the paradoxical behavior of [CD4.sup.+][CD25.sup.+] T cells
26. Differentiation of Dendritic Cells from Human Embryonic Stem Cells
27. Regulatory T cells in transplantation
28. Interview: Immunogenicity: the elephant in the room for regenerative medicine?
29. Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy
30. Modelling late-onset diseases with induced pluripotent stem cells: a matter of time management
31. Defining and Overcoming the Immunological Barriers to Stem Cell Therapies
32. Immunological Tolerance: Scanning a Barren Landscape for Signs of Sustained Growth
33. Ectopic Transplantation of Tissues Under the Kidney Capsule
34. Genetic Modification of Dendritic Cells Through the Directed Differentiation of Embryonic Stem Cells
35. Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies
36. Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells
37. Embryonic stem cells: a novel source of dendritic cells for clinical applications
38. Embryonic stem cells: a medical dream? Modern biology sometimes raises difficult and controversial issues which affect the lives we lead and the environment in which we live. This column examines such ethical problems
39. Probing Dendritic Cell Function by Guiding the Differentiation of Embryonic Stem Cells
40. Immune privilege induced by regulatory T cells in transplantation tolerance
41. Infectious tolerance and the long-term acceptance of transplanted tissue
42. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
43. Embryonic stem cells and the challenge of transplantation tolerance
44. Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby
45. Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms
46. Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
47. Immunotherapy with iPSC-derived dendritic cells brings a new perspective to an old debate: autologous versus allogeneic?
48. Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning
49. Therapeutic aspects of tolerance
50. Wellhead gas compression extends life of beam-pumped wells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.